Clinical Operations Unit

As an Investigator site, Gustave Roussy has a Clinical Operations Unit ensuring clinical research activities for all therapeutic trials and clinical studies.  This service is provided regardless of the sponsor category (pharma industries, biotech, scientific associations, academic institutions), at all development phases (from early to advanced phase) including strategic areas such as Molecular Medicine, Antitumor Immunology, DNA repair and rare Cancers.

Le 10 juin 2021

The international meeting of the American Society of Clinical Oncology (ASCO) gathers every year the world’s leading cancer experts. In 2021, ASCO meeting is virtual. Oral, Poster Discussion, and Poster Sessions, as well as track-based Clinical Science Symposia, are available on ASCO's website.

Le 2 Juin 2021

ASCO 2021

Metastatic or recurrent cancer of the uterine cervix: Encouraging results with second generation immunotherapy

An early trial presented by the Institut Bergonié and Gustave Roussy at the 2021 ASCO Conference shows that patients with metastatic or recurrent cancer of the cervix may benefit from dual immunotherapy. The new generation agent, Simlukafusp Alfa, a variant of interleukin-2, shows promising signs of efficacy by doubling the response to anti-PD-L1 immunotherapy alone, without causing major adverse effects.

Les professionnels de la recherche clinique : plus de 20 métiers différents interagissent pour conduire un essai clinique au bénéfice du patient.

29 april 2021

Gustave Roussy joins the Worldwide Innovative Network (WIN) in personalized cancer medicine consortium- WIN Consortium

Gustave Roussy and Worldwide Innovative Networking (WIN) in personalized cancer medicine consortium join forces to advance innovative cancer research.